Study: Investments in Global Fund strengthen German companies

German companies benefit from the policy of investing in The Global Fund to Fight AIDS, Tuberculosis and Malaria, according to a report by the development organization One.

Around €940 million ($1.09 billion) is said to have flowed to German manufacturers from 2010 to 2024, the report released on Thursday said.

Among the the things the German companies sold were diagnostics, HIV and tuberculosis therapy products and mosquito nets.

Germany has reportedly been the fourth-largest public donor to the fund since 2002, with a total of €5.4 billion, or 7.9% of the total funds.

According to One, The Global Fund is the central financing instrument in development cooperation to stop HIV, AIDS, tuberculosis and malaria. It is said to be active in more than 120 countries and mobilizes around $5 billion annually to combat deadly infectious diseases.

Since its inception, the fund is said to have saved around 70 million lives, Lisa Ditlmann, director of One in Germany, said in a statement. Around 5.6 million of these are reportedly directly attributable to German aid, she said.

"Our analysis shows: These investments not only save lives, they also strengthen German companies," Ditlmann said. "The Global Fund is a success story and a shining example of what we can achieve with the right investments and smart policies."

However, the German government plans to significantly cut back its support for global health projects. For instance, the fund is expected to receive millions of euros less in the coming years.